For Personalized Prevention And Treatment Strategies
Hereditary Cancer Tests
Mapping the human genome has made it possible to quickly and economically refine a patient’s cancer risk through an analysis of inherited mutations. Our inherited cancer test panel is one of the industry’s largest.
Screening for hereditary cancers gives patients—especially those with a family history of cancer—relevant information about their cancer risk, and helps providers make more informed decisions and develop an appropriate preventative or treatment plan.
- Bone Cancers
- Skin Cancers
- Breast & Gynecologic
- Endocrine
- Head & Neck
- Nervous system
- Soft tissue
- Colorectal
- Hematopoietic
- GI Tract
Carrier Screening
Our carrier screening allows providers to determine if prospective parents carry a genetic mutation that could cause a serious inherited disorder in their baby, such as cystic fibrosis, sickle cell and Tay-Sachs disease.
Newborn Genetics Tests
Newborn genetic screening identifies genetic disorders in infants. Early intervention to treat these disorders can help eliminate or reduce symptoms that might otherwise cause a lifetime of disability.
- Polypharmacy
- Cardiac
- Gastroenterology
- Pain
- Psychotropic
- Surgery
Pharmacogenetics Tests
Studies have shown that incorporating genetic factors into the prescribing process can help improve efficacy, reduce adverse effects and help avoid drug-drug interactions.
Our pharmacogenetic tests help healthcare providers target treatment and medications to a patient’s genetics by analyzing the genes that produce the specific drug targets, or enzymes that metabolize a medication or are associated with immune response.